Menarini investing 60 million euros in infrastructure in Germany

Family-owned Menarini Group, Italy’s largest biopharma company, continues to increase its investments in Italy and abroad.

Headquartered in Florence, the company has recently inaugurated several new buildings at its Berlin, Germany-based company, Berlin Chemie- Menarini. The five new structures, some built ex-novo and others renovated, represent an investment of 60 million euros ($67.3 million) over a total area of 14,000 square meters.

The investment in Berlin Chemie – Menarini’s new structures began in 2013 and today more than 95% of the project has been completed. It was presented to the German press and to various local authorities including the Mayor of the city of Berlin, Michael Müller, who is also Prime Minister of the city-state of Berlin. In Berlin, the Menarini Group has two manufacturing plants and an R & D center specializing in preclinical development and clinical research.